Eutilex.Co.,Ltd (KOSDAQ:263050)
South Korea · Delayed Price · Currency is KRW 725.00
-15.00 (-2.03%)
At close: Jan 30, 2026
Eutilex.Co.,Ltd Market Cap
Eutilex.Co.,Ltd has a market cap or net worth of 26.7 billion as of January 30, 2026. Its market cap has decreased by -62.71% in one year.
Market Cap
26.70B
Enterprise Value
37.18B
Revenue
10.54B
Ranking
n/a
PE Ratio
n/a
Stock Price
725.00
Market Cap Chart
Since December 24, 2018, Eutilex.Co.,Ltd's market cap has decreased from 567.29B to 26.70B, a decrease of -95.29%. That is a compound annual growth rate of -34.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 26.70B | -34.57% |
| Dec 30, 2025 | 40.81B | -42.41% |
| Dec 30, 2024 | 70.86B | -42.97% |
| Dec 28, 2023 | 124.25B | -49.10% |
| Dec 29, 2022 | 244.11B | -29.44% |
| Dec 30, 2021 | 345.97B | -38.90% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 24, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MOA Life Plus | 67.15B |
| NGeneBio | 50.45B |
| J2KBIO | 49.65B |
| Aptamer Sciences | 47.42B |
| SCM Lifescience | 36.42B |
| Kainos Medicine | 35.56B |
| Epibiotech | 33.40B |
| ADBiotech | 30.35B |